Cargando…

CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II

Under non-inflammatory conditions HLA class II is predominantly expressed on hematopoietic cells. Therefore, donor CD4 T-cells after allogeneic stem cell transplantation (alloSCT) may mediate graft-vs.-leukemia reactivity without graft-vs.-host disease (GVHD). We analyzed immune responses in four pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Balen, Peter, van Bergen, Cornelis A. M., van Luxemburg-Heijs, Simone A. P., de Klerk, Wendy, van Egmond, Esther H. M., Veld, Sabrina A. J., Halkes, Constantijn J. M., Zwaginga, Jaap-Jan, Griffioen, Marieke, Jedema, Inge, Falkenburg, J. H. Frederik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305328/ https://www.ncbi.nlm.nih.gov/pubmed/30619360 http://dx.doi.org/10.3389/fimmu.2018.03016

Ejemplares similares

Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets
por: Griffioen, Marieke, et al.
Publicado: (2016)

Loss of the GPI‐anchor in B‐lymphoblastic leukemia by epigenetic downregulation of PIGH expression
por: Loeff, Floris C., et al.
Publicado: (2018)

HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study
por: van Balen, Peter, et al.
Publicado: (2020)

Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing
por: Huisman, W., et al.
Publicado: (2022)

Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens
por: Fuchs, Kyra J., et al.
Publicado: (2020)

The allogeneic HLA-DP-restricted T-cell repertoire provoked by allogeneic dendritic cells contains T cells that show restricted recognition of hematopoietic cells including primary malignant cells
por: Laghmouchi, Aicha, et al.
Publicado: (2019)

Integrated whole genome and transcriptome analysis identified a therapeutic minor histocompatibility antigen encoded by an alternative ITGB2 transcript
por: Pont, Margot J, et al.
Publicado: (2015)

A Polymorphism in the Splice Donor Site of ZNF419 Results in the Novel Renal Cell Carcinoma-Associated Minor Histocompatibility Antigen ZAPHIR
por: Broen, Kelly, et al.
Publicado: (2011)

Influence of Polymorphisms in Innate Immunity Genes on Susceptibility to Invasive Aspergillosis after Stem Cell Transplantation
por: de Boer, Mark G. J., et al.
Publicado: (2011)

Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase
por: Kremer, Anita N., et al.
Publicado: (2020)

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction
por: van Balen, Peter, et al.
Publicado: (2018)

Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion
por: Koster, Eva A. S., et al.
Publicado: (2023)

Common Minor Histocompatibility Antigen Discovery Based upon Patient Clinical Outcomes and Genomic Data
por: Armistead, Paul M., et al.
Publicado: (2011)

Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity
por: Laghmouchi, Aicha, et al.
Publicado: (2022)

The Value of Online Algorithms to Predict T-Cell Ligands Created by Genetic Variants
por: van der Lee, Dyantha I., et al.
Publicado: (2016)

Human T cells recognize HLA-DP–bound peptides in two orientations
por: Klobuch, Sebastian, et al.
Publicado: (2022)

Gut-grabbing T cells trigger GVHD
por: Van Epps, Heather L.
Publicado: (2005)

Anti Thymocyte Globulin-Based Treatment for Acquired Bone Marrow Failure in Adults
por: Tjon, Jennifer M.-L., et al.
Publicado: (2021)

Durable Remission of Renal Cell Carcinoma in Conjuncture with Graft versus Host Disease following Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion: Rule or Exception?
por: van Bergen, Cornelis A. M., et al.
Publicado: (2014)

P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL
por: Oosten, L., et al.
Publicado: (2022)

Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients
por: van der Zouwen, Boris, et al.
Publicado: (2023)

Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT
por: van der Velden, Walter J. F. M., et al.
Publicado: (2021)

Long‐term in vitro persistence of magnetic properties after magnetic bead‐based cell separation of T cells
por: Laghmouchi, Aicha, et al.
Publicado: (2020)

Modulation of the Major Histocompatibility Complex Class II–Associated Peptide Repertoire by Human Histocompatibility Leukocyte Antigen (Hla)-Do
por: van Ham, Marieke, et al.
Publicado: (2000)

Magnitude of Off-Target Allo-HLA Reactivity by Third-Party Donor-Derived Virus-Specific T Cells Is Dictated by HLA-Restriction
por: Huisman, Wesley, et al.
Publicado: (2021)

P74. A Good Manufacturing Practice procedure to generate therapeutic numbers of highly pure anti-leukaemic virus-specific T-cells
por: van Loenen, MM, et al.
Publicado: (2014)

Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation
por: de Kort, Elizabeth A., et al.
Publicado: (2019)

Modulation of Allogeneic CD8(+) T-Cell Response by DZNep Controls GVHD While Preserving Hematopoietic Chimerism
por: Wang, Jina, et al.
Publicado: (2013)

Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium
por: DeFilipp, Zachariah, et al.
Publicado: (2021)

Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD
por: Maurer, Katie, et al.
Publicado: (2023)

Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1
por: Oostvogels, R, et al.
Publicado: (2013)

Risk Factors for Alloimmunisation after red blood Cell Transfusions (R-FACT): a case cohort study
por: Zalpuri, Saurabh, et al.
Publicado: (2012)

The Relationship between STR-PCR Chimerism Analysis and Chronic GvHD Following Hematopoietic Stem Cell Transplantation
por: Mousavi, Seyed Asadollah, et al.
Publicado: (2017)

Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD
por: Hildebrandt, G C, et al.
Publicado: (2011)

Inhibition of Dendritic Cell Activation and Modulation of T Cell Polarization by the Platelet Secretome
por: Saris, Anno, et al.
Publicado: (2021)

Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes
por: Herzog, Shannon, et al.
Publicado: (2023)

GVHD Prophylaxis 2020
por: Gooptu, Mahasweta, et al.
Publicado: (2021)

Spin transportation and spin injection in mesoscopic metal and semiconductor devices
por: Wees, B. J. Van, et al.
Publicado: (2001)

High-Throughput Identification of Potential Minor Histocompatibility Antigens by MHC Tetramer-Based Screening: Feasibility and Limitations
por: Hombrink, Pleun, et al.
Publicado: (2011)

The utility of biomarkers in acute GVHD prognostication
por: Spyrou, Nikolaos, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nncbtf358vv8ggat4kmil0ljg3